Şükrü Yıldız

ORCID: 0000-0003-1490-365X · 7 papers in corpus · active 2012-2024

Study types

  • article 5
  • other 2

Condition tags

  • endometriosis 4
  • endometrioma 4
  • chronic_pelvic_pain 1
  • adenomyosis 1
other 2024
Revista da Associacao Medica Brasileira (1992) ·doi:10.1590/1806-9282.20240485

OBJECTIVE: Endometriosis is a disease in which stromal cells and endometrial glands extend outside of the uterine cavity. Nevertheless, treatment failure and recurrence cause difficulties in management. This study aimed to evaluate the rece…

other 2023
Revista da Associacao Medica Brasileira (1992) ·doi:10.1590/1806-9282.20221720

OBJECTIVE: Our goal was to contrast the prognoses of patients with endometrial cancer who had adenomyosis against those that did not. METHODS: All patients who had received surgical staging for hysterectomy-based endometrial cancer had the…

article 2022
·doi:10.4274/bmj.galenos.2022.2021.10-4

Objective: Metabolic effects of dienogest (DNG) may lead to unintended lipid levels, which may predispose to cardiovascular diseases. The main objective of this study was to reveal effects of DNG only treatment on lipid profile.

article 2020
·doi:10.17826/cumj.635204

Purpose: The aim of this study was to assess the effect of hemostasis by electrocoagulation versus suture on endometrioma recurrence and pregnancy rates after laparoscopic cystectomy in uni/bilateral endometriomas. Materials and Methods: Fo…

article 2020
Ginekologia polska ·doi:10.5603/gp.2020.0053

OBJECTIVES: To evaluate the rates of pain and mass recurrence of the patients over 40 years old with endometriosis who underwent ovarian cystectomy or uni/bilateral oophorectomy. MATERIAL AND METHODS: A retrospective study was conducted wit…

article 2014

In gynecology, the serum CA125 and CA19-9 levels are elevated in patients with malignant and benign conditions especially in ovarian tumors. Although endometriosis is a benign condition, increased levels of the tumor markers CA125 and CA19-…

article 2012
·doi:10.5455/gmj-30-2012-93

In gynecology, the serum CA125 and CA19-9 levels are elevated in patients with malignant and benign conditions especially in ovarian tumors. Although endometriosis is a benign condition, increased levels of the tumor markers CA125 and CA19-…